Families using Nara Organics infant formula should immediately discontinue use of the product. The company has initiated a voluntary recall of every lot of its Powdered Infant Formula currently on the market due to the potential presence of Clostridium botulinum. This decision follows reports from the FDA and CDC regarding three infants in California, Washington, and Pennsylvania who required hospitalization for infant botulism after consuming the formula.
While the affected infants were treated with Botulism Immune Globulin Intravenous (BabyBIG) and no fatalities have been reported, the situation is being treated with extreme urgency. Although Nara Organics reports that internal testing has not yet confirmed the presence of C. botulinum in the formula, the company is proceeding with the recall as a precautionary measure while collaborating with health officials to investigate the source of the issue.
Understanding the Risks and Symptoms of Infant Botulism
Infant botulism is a rare but life-threatening condition that occurs when a baby ingests Clostridium botulinum spores. These spores can grow in an infant’s developing intestinal tract and release dangerous neurotoxins. Unlike adults and older children, whose mature digestive systems can typically prevent these spores from growing, infants are particularly susceptible to this type of colonization.
Parents and caregivers should monitor their children closely for the following warning signs:
- Persistent constipation
- Diminished interest in feeding or poor appetite
- Drooping eyelids (ptosis)
- Pupils that are slow to react or unresponsive
- Noticeable “floppiness” or low muscle tone
- Difficulty with sucking or swallowing
- A cry that sounds weak or significantly different than usual
- General physical weakness
- Respiratory distress or breathing difficulties
Seek emergency medical care immediately if your child has consumed Nara formula and exhibits any of these symptoms.
Identifying Recalled Nara Organics Formula Products
The scope of this recall includes all batches of Nara Organics Powdered Infant Formula sold through Target stores, Target.com, and Nara.com between July 2025 and June 2026. The specific products include:
- Nara Organics Whole Milk Infant Formula (700g) — UPC 860013251901
- Nara Organics Whole Milk Infant Formula (400g) — UPC 860013251918
To determine if your formula is included, locate the lot code printed on the bottom of the canister. The following lot codes are part of the recall:
- 408125075E14F2
- 708125076E14F2
- 708125083E14F2
- 408125139E14F2
- 708125141E14F2
- 708125145E14F2
- 708125174E14F2 (Linked to hospitalization)
- 709125273E14F2
- 709125280E14F2 (Linked to hospitalization)
- 709125288E14F2 (Linked to hospitalization)
- 409125307E14F2
- 70926019ENNB
- 70926029ENNB
- 70926035ENNB
- 70926039ENNB
- 70926042ENNB
Steps for Parents and Caregivers to Take Immediately
If you have any of the recalled formula in your home, stop using it immediately. Even if the powder looks, smells, and tastes normal, it may still contain harmful bacteria. Do not attempt to feed it to your baby.
How to obtain a refund:
- Direct Nara.com Purchases: For orders placed in May or June 2026, Nara Organics will process refunds automatically.
- Target and Other Retailers: Take a clear photograph of the lot code on the bottom of the can and complete the refund request form on the Nara Organics website.
- In-Store Returns: Products purchased at Target can also be returned directly to any Target location for a full refund.
For additional assistance, parents can reach out to the company via email at [email protected].
How to File a Report Regarding Contaminated Formula
If your child has experienced an adverse health event related to this formula, it is important to notify the FDA. You can submit a report through the following channels:
- Utilize the FDA SmartHub to report a product issue.
- Submit a Voluntary MedWatch form through the official FDA website.
- Mail a completed paper MedWatch form directly to the FDA.
Current Status of the Nara Organics Investigation
The investigation into how the contamination may have occurred is ongoing. The FDA and CDC alerted Nara Organics to the clusters of botulism cases on June 12, 2026. While the company maintains that current testing has not yet detected C. botulinum in their products, they are working alongside state and federal agencies to identify the root cause. Nara Organics has pledged to keep the public informed as new details emerge from the safety investigation.
Summary: This recall is a critical safety measure intended to protect the most vulnerable members of our families. If you possess any Nara Organics Powdered Infant Formula, prioritize your child’s health by discarding the product or returning it for a refund. Stay vigilant for symptoms of infant botulism and consult a pediatrician immediately if you have any concerns about your baby’s health.
